# EDGAR Filing Document

**Accession Number:** 0001089815
**File Stem:** 0001437749-25-038869
**Filing Date:** 2025-12
**Character Count:** 8653
**Document Hash:** 9e26c52f64fc121e8fd0df381e70ea7d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-038869.hdr.sgml**: 20251229

**ACCESSION NUMBER**: 0001437749-25-038869

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251229

**DATE AS OF CHANGE**: 20251229

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Elite Health Systems Inc.
- **CENTRAL INDEX KEY:** 0001089815
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 521842411
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-56875
- **FILM NUMBER:** 251610400

**BUSINESS ADDRESS:**
- **STREET 1:** 1131 W 6TH STREET
- **STREET 2:** SUITE 225
- **CITY:** ONTARIO
- **STATE:** CA
- **ZIP:** 91762
- **BUSINESS PHONE:** 949-249-1170

**MAIL ADDRESS:**
- **STREET 1:** 1131 W 6TH STREET
- **STREET 2:** SUITE 225
- **CITY:** ONTARIO
- **STATE:** CA
- **ZIP:** 91762

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Elite Health Systems, Inc.
- **DATE OF NAME CHANGE:** 20241002

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** U.S. NeuroSurgical Holdings, Inc.
- **DATE OF NAME CHANGE:** 20150828

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** US NEUROSURGICAL INC
- **DATE OF NAME CHANGE:** 19990630
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** jeereddi Prasad Anjaneya
- **CENTRAL INDEX KEY:** 0001999391

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **STREET 1:** 840 TOWNE CENTER DRIVE
- **CITY:** POMONA
- **STATE:** AR
- **ZIP:** 91767

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Elite Health Systems Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.01 per share**

*(Title of Class of Securities)*

**90336K101**

*(CUSIP Number)*

**Dr. Prasad Jeereddi**<br>1161 W. 6th Street<br>Suite 225<br>Ontario Z4 91762<br>(949)249-1170

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**11/04/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **90336K101** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**jeereddi Prasad Anjaneya** | Name of reporting person<br>**jeereddi Prasad Anjaneya** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**3356663.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**222114.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**3356663.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**222114.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3578777.00** | Aggregate amount beneficially owned by each reporting person<br>**3578777.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**12.7%** | Percent of class represented by amount in Row (11)<br>**12.7%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** Represents 222,114 shares held by an entity which the Reporting Person is a managing member and major shareholder.

| **CUSIP No.** | **90336K101** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Jeereddi Praveena** | Name of reporting person<br>**Jeereddi Praveena** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**1389520.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**35000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**1389520.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**35000.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1424520.00** | Aggregate amount beneficially owned by each reporting person<br>**1424520.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**5.1%** | Percent of class represented by amount in Row (11)<br>**5.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** Represents 35,000 shares held by a family trust.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.01 per share

**(b) Name of Issuer:**
Elite Health Systems Inc.

**(c) Address of Issuer's Principal Executive Offices:**
1131 W 6TH STREET, SUITE 225, ONTARIO, CA, 91762

**Item 4. Purpose of Transaction**

See response to Item 3 above.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The aggregate percentage of shares of common stock reported owned by each Reporting Person is based upon the number of shares of the Issuer's common stock outstanding as of November 4, 2025, which as of such date was 28,200,424 shares.

As of the date hereof, Prasad A. Jeereddi directly owned 3,578,777 shares.
Percentage: Approximately 12.69%

As of the date hereof, Praveena. Jeereddi directly owned 1,424,520 shares.
Percentage: Approximately 5.05%

**(b)**
Prasad A. Jeereddi
1. Sole power to vote or direct vote: 3,356,663
2. Shared power to vote or direct vote: 222,114
3. Sole power to dispose or direct the disposition: 3,356,663
4. Shared power to dispose or direct the disposition: 222,114

Praveena Jeereddi
1. Sole power to vote or direct vote: 1,389,520
2. Shared power to vote or direct vote: 35,000
3. Sole power to dispose or direct the disposition: 1,389,520
4. Shared power to dispose or direct the disposition: 35,000

**(c)**
Not applicable

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Neither Reporting Person has a contract, arrangement, undertaking or relationship with respect to securities of the Issuer.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** jeereddi Prasad Anjaneya

**Signature:** Dr. Prasad Jeereddi

**Name/Title:** Dr. Prasad Jeereddi

**Date:** 12/29/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Jeereddi Praveena

**Signature:** Dr. Praveena Jeereddi

**Name/Title:** Dr. Praveena Jeereddi

**Date:** 12/29/2025